Martin Shkreli earned the wrath of the Internet after his company jacked up the price of a sixty year-old drug from $18 to $750 per tablet. While the price hike — and Shkreli’s smug reaction to the justified public outcry — might seem like a tough pill to swallow, it turns out that the former hedge-funder dubbed Pharma Bro might be just what the doctor ordered. As WaPo’s Carolyn Johnson explains: “Shkreli’s actions were shocking for a simple reason: It was an unusual moment of complete transparency in health care, where motives, prices and how the system works are rarely ever talked about so nakedly.” This could be a wake-up call moment in modern health care (unless the insomnia medication the industry prescribed makes us sleep through the alarm).

+ Wired: How prescription drugs get so wildly expensive.

+ Slate: Generics companies were supposed to make drugs cheaper, but some have become the new villains of health care.

+ From Bloomberg, the interesting story of how marketing turned the EpiPen into a billion-dollar business.